Search by Drug Name or NDC

    NDC 30142-0096-91 flu and severe cold and cough 650; 20; 10 mg/1; mg/1; mg/1 Details

    flu and severe cold and cough 650; 20; 10 mg/1; mg/1; mg/1

    flu and severe cold and cough is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Kroger Company. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 30142-0096
    Product ID 30142-096_adf29187-2c34-46e2-820f-fee86a24345d
    Associated GPIs
    GCN Sequence Number 064452
    GCN Sequence Number Description d-methorphan/PE/acetaminophen POWD PACK 20-10-650 ORAL
    HIC3 B4M
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-ANALGESIC COMB
    GCN 14355
    HICL Sequence Number 008885
    HICL Sequence Number Description DEXTROMETHORPHAN HBR/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name flu and severe cold and cough
    Proprietary Name Suffix daytime
    Non-Proprietary Name Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Kroger Company
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 30142-0096-91 (30142009691)

    NDC Package Code 30142-096-91
    Billing NDC 30142009691
    Package 6 POWDER, FOR SOLUTION in 1 CARTON (30142-096-91)
    Marketing Start Date 2012-01-17
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL bd85e0eb-a252-4693-9d2f-ca7304c35abd Details

    Revised: 7/2020